USANA Health Sciences (NYSE:USNA) Sets New 1-Year Low at $37.05

USANA Health Sciences, Inc. (NYSE:USNA) hit a new 52-week low during trading on Monday . The company traded as low as $37.05 and last traded at $37.23, with a volume of 5929 shares changing hands. The stock had previously closed at $37.70.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on USNA shares. DA Davidson cut their price target on shares of USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating on the stock in a report on Thursday, July 25th. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th.

USANA Health Sciences Trading Down 3.1 %

The firm has a market cap of $695.90 million, a price-to-earnings ratio of 11.74, a PEG ratio of 1.26 and a beta of 0.90. The company has a fifty day moving average price of $42.10 and a 200-day moving average price of $45.10.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.11). The company had revenue of $212.87 million during the quarter, compared to analyst estimates of $218.64 million. USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.13%. During the same period in the previous year, the firm posted $0.89 earnings per share. As a group, research analysts forecast that USANA Health Sciences, Inc. will post 2.5 earnings per share for the current fiscal year.

Insider Activity at USANA Health Sciences

In other news, insider Paul A. Jones sold 6,266 shares of the firm’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total transaction of $240,489.08. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, insider Paul A. Jones sold 6,266 shares of the stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total transaction of $240,489.08. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Gilbert A. Fuller sold 674 shares of USANA Health Sciences stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 23,638 shares of company stock worth $1,024,629. 0.33% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Quest Partners LLC acquired a new position in USANA Health Sciences in the 4th quarter valued at $66,000. CWM LLC lifted its stake in shares of USANA Health Sciences by 21.8% in the first quarter. CWM LLC now owns 1,543 shares of the company’s stock worth $75,000 after buying an additional 276 shares in the last quarter. BOKF NA boosted its position in USANA Health Sciences by 274.5% during the first quarter. BOKF NA now owns 2,771 shares of the company’s stock worth $133,000 after acquiring an additional 2,031 shares during the last quarter. Trexquant Investment LP purchased a new stake in USANA Health Sciences during the 4th quarter valued at about $266,000. Finally, Price T Rowe Associates Inc. MD raised its holdings in USANA Health Sciences by 9.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock valued at $284,000 after acquiring an additional 494 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.